Cutaneous Adnexal Adenocarcinoma: Genomic Analysis and Successful HER2-targeted Therapy of Metastatic Disease

被引：1
|
作者：
Hirano-Lotman, Yui [1 ]
Ishida, Yoshihiro [1 ]
Endo, Yuichiro [1 ]
Ogawa, Seishi [2 ]
Kabashima, Kenji [1 ]
机构：
[1] Kyoto Univ, Dept Dermatol, Grad Sch Med, 54 Shogoin Kawahara Cho,Sakyo Ku, Kyoto 6068507, Japan
[2] Kyoto Univ, Grad Sch Med, Pathol & Tumor Biol, Kyoto, Japan
来源：
ACTA DERMATO-VENEREOLOGICA | 2023年 / 103卷
关键词：
CHEMOTHERAPY; PERTUZUMAB;
D O I：
10.2340/actadv.v103.9399
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Her2-Targeted Therapy Induces Autophagy in Esophageal Adenocarcinoma Cells
    Janser, Felice A.
    Adams, Olivia
    Buetler, Vanessa
    Schlaefli, Anna M.
    Dislich, Bastian
    Seiler, Christian A.
    Kroll, Dino
    Langer, Rupert
    Tschan, Mario P.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (10)
  • [2] HER2-targeted therapy is changing
    Matsumura, Noriomi
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2024, 13 (04): : 325 - 325
  • [3] HER2-Targeted Therapy in Osteosarcoma
    Gill, Jonathan
    Hingorani, Pooja
    Roth, Michael
    Gorlick, Richard
    CURRENT ADVANCES IN OSTEOSARCOMA: CLINICAL PERSPECTIVES: PAST, PRESENT AND FUTURE, 2ND EDITION, 2020, 1257 : 55 - 66
  • [4] Resistance mechanisms to HER2-targeted therapy in gastroesophageal adenocarcinoma: A systematic review
    Blange, Dionne
    Stroes, Charlotte I.
    Derks, Sarah
    Bijlsma, Maarten F.
    van Laarhoven, Hanneke W. M.
    CANCER TREATMENT REVIEWS, 2022, 108
  • [5] HER3 mediates acquired resistance to HER2-targeted therapy in esophageal adenocarcinoma
    Ebbing, Eva A.
    Medema, Jan Paul
    Meijer, Sybren L.
    Krishnadath, Kausilia K.
    Henegouwen, Mark I. van Berge
    Bijlsma, Maarten F.
    van Laarhoven, Hanneke W. M.
    CANCER RESEARCH, 2015, 75
  • [6] HER2-targeted therapy influences CTC status in metastatic breast cancer
    Thomas M. Deutsch
    Sabine Riethdorf
    Carlo Fremd
    Manuel Feisst
    Juliane Nees
    Chiara Fischer
    Andreas D. Hartkopf
    Klaus Pantel
    Andreas Trumpp
    Florian Schütz
    Andreas Schneeweiss
    Markus Wallwiener
    Breast Cancer Research and Treatment, 2020, 182 : 127 - 136
  • [7] HER2-targeted therapy influences CTC status in metastatic breast cancer
    Deutsch, Thomas M.
    Riethdorf, Sabine
    Fremd, Carlo
    Feisst, Manuel
    Nees, Juliane
    Fischer, Chiara
    Hartkopf, Andreas D.
    Pantel, Klaus
    Trumpp, Andreas
    Schuetz, Florian
    Schneeweiss, Andreas
    Wallwiener, Markus
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 182 (01) : 127 - 136
  • [8] The role of autophagy in HER2-targeted therapy
    Felice, Janser A.
    Mario, Tschan P.
    Rupert, Langer
    SWISS MEDICAL WEEKLY, 2019, 149
  • [9] The economic burden of HER2-targeted therapy among metastatic breast cancer patients
    Forero-Torres, Andres
    Anupindi, Vamshi Ruthwik
    Yeaw, Jason
    DeKoven, Mitch
    Feliciano, Joseph
    Richhariya, Akshara
    CANCER RESEARCH, 2020, 80 (04)
  • [10] Molecular mechanisms of resistance to HER2-targeted therapy
    FJ Esteva
    Breast Cancer Research, 11
12345